Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) Change In Inventory : ¥0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co Change In Inventory?

Hebei Changshan Biochemical Pharmaceutical Co's change in inventory for the quarter that ended in Mar. 2025 was ¥0.0 Mil. It means Hebei Changshan Biochemical Pharmaceutical Co's inventory stayed the same from Dec. 2024 to Mar. 2025 .

Hebei Changshan Biochemical Pharmaceutical Co's change in inventory for the fiscal year that ended in Dec. 2024 was ¥190.0 Mil. It means Hebei Changshan Biochemical Pharmaceutical Co's inventory declined by ¥190.0 Mil from Dec. 2023 to Dec. 2024 .

Hebei Changshan Biochemical Pharmaceutical Co's Total Inventories for the quarter that ended in Mar. 2025 was ¥1,287.9 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Hebei Changshan Biochemical Pharmaceutical Co's Days Inventory for the quarter that ended in Mar. 2025 was 613.18.

Inventory Turnover measures how fast the company turns over its inventory within a year. Hebei Changshan Biochemical Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.15.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Hebei Changshan Biochemical Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 5.17.

Hebei Changshan Biochemical Pharmaceutical Co Change In Inventory Historical Data

The historical data trend for Hebei Changshan Biochemical Pharmaceutical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hebei Changshan Biochemical Pharmaceutical Co Change In Inventory Chart

Hebei Changshan Biochemical Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-479.01

-398.02

-156.01

161.28

190.00

Hebei Changshan Biochemical Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Hebei Changshan Biochemical Pharmaceutical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Hebei Changshan Biochemical Pharmaceutical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1336.8435	/	198.942	*	365 / 4
	=	613.18

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Hebei Changshan Biochemical Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	198.942	/	1336.8435
	=	0.15

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Hebei Changshan Biochemical Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1336.8435	/	258.703
	=	5.17

Hebei Changshan Biochemical Pharmaceutical Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Hebei Changshan Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800

Website

http://www.hbcsbio.com

Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.

Executives

Li Zhi Hua	Executives
Wang Jun	Executives
Ding Jian Wen	Directors, executives
Huang Guo Sheng	Executives
Gao Shu Hua	Directors, executives
Chen Xi	Director
Cai Hao	Executives
Ji Sheng Li	Directors, executives
Li Xin	Securities Affairs Representative
Zhang Wei	Secretary Dong
Liu Jian	Executives
Zhang Zhi Ying	Executives
Guo Yan Xing	Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines